Are all ACE inhibitors ace in treatment of essential hypertension?Josep Vidal-Alaball
Abstract: ACE inhibitors (ACEi) are widely recommended and used for treatment of hypertension. There are number of ACEi to choose from. It make sense to use the one that that has been shown to be most effective in prevention of serious hypertension complication such as stroke. If there is more that one choice it make sense to use the one with lower acquisition cost. In this paper we are looking into the evidence for using ACEi as a first line treatment for hypertension and to try and find out which ACEi has been associated with the best clinical outcome. We found no long-term trials comparing ACEi and placebo for treatment of hypertension. We found no head-to-head studies directly comparing the main four ACEi’s, commonly prescribed in England. On the basis of the evidence presented, lisinopril is the only commonly used ACEi that can be considered a first line treatment for hypertension. There is some evidence for ramipril, although this is not as strong. There is no substantial evidence of the effectiveness of enalapril and in the presence of a proven treatment (lisinopril) it makes no sense to use it for the treatment of hypertension. There is no evidence that perindopril improves mortality or stroke rate in patients with hypertension. Perindopril is no better than placebo for treatment of patients with previous TIA or stroke.
Arteriovenous blood gas agreement: A research journeykellyam18
This presentation discusses the state of evidence for arteriovenous blood gas agreement for pH, pCO2, bicarbonate and base excess and how that fits into clinical decision-making. It also describes the resaerch journey of a smal clinical team to answer important clinical questions and address an issue of concern to patients.
Blood Pressure Targets 2017.Still Struggling for the Right Answermagdy elmasry
Blood Pressure Targets 2017.Guidelines For Hypertension 2011-2015.Does SPRINT change our approach to BP targets?
SPRINT vs. ACCORD.Updated Hypertension Guidelines Released by ACP, AAFP
Are all ACE inhibitors ace in treatment of essential hypertension?Josep Vidal-Alaball
Abstract: ACE inhibitors (ACEi) are widely recommended and used for treatment of hypertension. There are number of ACEi to choose from. It make sense to use the one that that has been shown to be most effective in prevention of serious hypertension complication such as stroke. If there is more that one choice it make sense to use the one with lower acquisition cost. In this paper we are looking into the evidence for using ACEi as a first line treatment for hypertension and to try and find out which ACEi has been associated with the best clinical outcome. We found no long-term trials comparing ACEi and placebo for treatment of hypertension. We found no head-to-head studies directly comparing the main four ACEi’s, commonly prescribed in England. On the basis of the evidence presented, lisinopril is the only commonly used ACEi that can be considered a first line treatment for hypertension. There is some evidence for ramipril, although this is not as strong. There is no substantial evidence of the effectiveness of enalapril and in the presence of a proven treatment (lisinopril) it makes no sense to use it for the treatment of hypertension. There is no evidence that perindopril improves mortality or stroke rate in patients with hypertension. Perindopril is no better than placebo for treatment of patients with previous TIA or stroke.
Arteriovenous blood gas agreement: A research journeykellyam18
This presentation discusses the state of evidence for arteriovenous blood gas agreement for pH, pCO2, bicarbonate and base excess and how that fits into clinical decision-making. It also describes the resaerch journey of a smal clinical team to answer important clinical questions and address an issue of concern to patients.
Blood Pressure Targets 2017.Still Struggling for the Right Answermagdy elmasry
Blood Pressure Targets 2017.Guidelines For Hypertension 2011-2015.Does SPRINT change our approach to BP targets?
SPRINT vs. ACCORD.Updated Hypertension Guidelines Released by ACP, AAFP
systolic BP lowering to a target of <130 mm Hg may reduce the risk of several important outcomes including risk of myocardial infarction, stroke, heart failure, and major cardiovascular events. No class of medications (i.e., angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, calcium channel blockers, or beta blockers) was significantly better than thiazides and thiazide-like diuretics as a first-line therapy for any outcome.
Similar to While controlling hypertension what is more important (20)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. Setting Target for Blood pressure and drug selection
• To set target for blood pressure reduction and selection of
antihypertensive medication are crucial steps in hypertension
management
• Neither BP target nor hypertensive medication will fit for all
individual
• Co-morbid conditions, age, gender, socioeconomic status and many
other factors contribute to set a BP target and choose appropriated
antihypertensive medication
8. ACC/AHA 2018: BP Thresholds and
Goals in Hypertension According to
Clinical Conditions
Hypertension. 2017 Nov 13. pii: HYP.0000000000000066.
9. ESC 2018: BP Thresholds and Goals in Hypertension
According to Clinical Conditions
10. 1. BP Target for Hypertension in Elder
population
JAMA. 2014;311(5):507-520, ; Canadian Journal of Cardiology 33 (2017) 557e576; JAPI 2013; vol. 61:17-23; The Journal of Clinical Hypertension Vol 16 | No 1 | January 2014
Guidelines Population Goal BP (mm Hg)
CHEP-2017 < 80 yrs <140/90
JNC 8 2014 > 60 years or older <150/90
ESH/ESC-2013 <80 years of Age <140/90;
Elderly > 80 years of
age
SBP 140-150
ASH/ISH- 2013
60-80 yrs <140/90
>80 yrs <150/90
NICE-2011
< 80 yrs <140/90
> 80 yrs <150/90
IGH-III 2013 > 55 yrs <140-145/90
11. 2. BP Target in Hypertension with CKD
Guideline Population Goal BP (mm Hg)
CHEP 2017 CKD
<140/90
JNC 8 CKD <140/90
ESH/ESC-2013
CKD, no Proteinuria <140/90
CKD + Proteinuria
<130/90
ASH/ISH- 2013 CKD <140/90
NICE-2011 CKD <140/90
IGH-III 2013 CKD <130/80
JAMA. 2014;311(5):507-520, ; Canadian Journal of Cardiology 33 (2017) 557e576; JAPI 2013; vol. 61:17-23; The Journal of Clinical Hypertension Vol 16 | No 1 | January 2014
12. Guidelines Population Blood pressure
Target (mm Hg)
ADA Guidelines (2017) DM <140/90 1A <130/80
2B
Hypertension Canada’s 2017 DM < 130/80
JNC8, 2014 DM <140/90
ASH, 2014 DM <140/90
JSH, 2014 DM <130/80
ESH, 2013 DM <140/85
KDIGO/KDOQI, 2013 DM <140/90
NICE Guidelines,2011 DM <140/90
3. BP Target in Hypertension with DM
The Journal of Clinical Hypertension Vol 18 | No 2 | February 2016, 95-100, ADA 2017, Canadian Journal of Cardiology 33 (2017) 557e576
13. Comparison between ESH 2018 and AHA 2107
guidelines
Points AHA 2017 ESH 2018
Category of BP Elevated BP
120-129 mm Hg SBP &
< 80 mm Hg DBP
Normal BP
120-129 mm Hg SBP &
< 80-84 mm Hg mm Hg DBP
BP Goal < 130/80 mm of Hg < 130/80 mm of Hg
Systolic not less than 120 &
Diastolic < 80-70
Initial therapy of
recommendation
ACE i/ ARB/CCBs/Thiazide
diuretics
Initial dual combination therapy.
ACEi or ARB+CCB or Diuretics
15. What Do Past Guidelines Suggest: Goal and
Treatment
JNC 8, 2014.
16. Evolution of BP thresholds for initiation and titration
of antihypertensive medication
• Pfeffer M. N Engl J Med. 2016
UKPDS 38
2017
2017 ACC/AHA
2017 ACC/AHA
Age < 65 yrs at low CVD risk
Age >65 yrs or at high CVD risk
Age < 65 yrs at low CVD risk
Age >65 yrs or at high CVD risk
N=143N=380 N=10,940
N=3,427
N=17,345
N=4,736
N=1,627
N=4,695 N=33,357 N=3,845 N=9,361
N=12,705
N=12,705
ACCOMPLISH
N=11,506
N=18,790
SPS3
N=1,148
Drug vs. Placebo
Comparing different drugs
Comparing different BP targets
17. Hypertension. 2017 Nov 13. pii: HYP.0000000000000066.
ACC/AHA 2017: Recommendation for pharmacological
and non-pharmacological therapy
25. Summary
• We can not conclude that BP target is more important or Antihypertensive
drug selection
• Both plays significant role in management of Hypertension
• In BP target and antihypertensive drug selection; co-morbid conditions,
patient’s age, gender, other ongoing medications, contraindication, patient
clinical condition are the major criteria that help to decide setting a BP
target and drug selection for treatment